MDPI and ACS Style
Toro, L.; Rojas, V.; Conejeros, C.; Ayala, P.; Parra-Lucares, A.; Ahumada, F.; Almeida, P.; Silva, M.F.; Bravo, K.; Pumarino, C.;
et al. A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development of Chronic Kidney Disease in Critical Care Patients with Sepsis: A Prospective Cohort. Biomolecules 2023, 13, 1481.
https://doi.org/10.3390/biom13101481
AMA Style
Toro L, Rojas V, Conejeros C, Ayala P, Parra-Lucares A, Ahumada F, Almeida P, Silva MF, Bravo K, Pumarino C,
et al. A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development of Chronic Kidney Disease in Critical Care Patients with Sepsis: A Prospective Cohort. Biomolecules. 2023; 13(10):1481.
https://doi.org/10.3390/biom13101481
Chicago/Turabian Style
Toro, Luis, Verónica Rojas, Carolina Conejeros, Patricia Ayala, Alfredo Parra-Lucares, Francisca Ahumada, Paula Almeida, MarÃa Fernanda Silva, Karin Bravo, Catalina Pumarino,
and et al. 2023. "A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development of Chronic Kidney Disease in Critical Care Patients with Sepsis: A Prospective Cohort" Biomolecules 13, no. 10: 1481.
https://doi.org/10.3390/biom13101481
